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Abstract
Background: The junctional zone (JZ), also called as the endometrial-myometrial junction, is related to
peristaltic-like movements in the non-pregnant uterus. Hyperperistalsis and dysperistalsis of uterus constructions might
underlie many important disorders such as dysmenorrhea, infertility, endometriosis, implantation failure. The major
proteins for uterine contraction of the non-pregnant uterus may be Oxytocin (OT) and oxytocin receptor (OTR). The
objective of this study was to inspect the expression of OTR in isthmic and mid-fundal parts of the uterine junctional
zone at different stages of the follicular cycle in patients with and without endometriosis.
Methods: Uterine biopsies containing endometrium and junctional zone were collected from the isthmic and
mid-fundal parts of the anterior wall after hysterectomy. The OTR expression was evaluated by immunohistochemistry.
Results: In the control uterus, OTR expression in the isthmic region was significantly higher than in the fundal region
in the proliferative phase (p < 0.05) but significantly lower in the secretory phase (p < 0.05). And the expression of OTR
in the proliferative phase was significantly higher than that in the secretory phase in both isthmic and fundal regions
(p = 0.000 and 0.049, respectively). However, in endometriosis uteri, OTR expression in the isthmic region showed no
significant difference with that in the fundal region in both proliferative and secretory phases (p = 0.597 and 0.736,
respectively). In both isthmic and fundal regions, OTR expression was not significantly different between the
proliferative phase and secretory phase (p = 0.084 and 0.222, respectively). OTR expression in fundal regions of revised
ASRM I and II endometriosis were lower than that of revised ASRM III and IV (p = 0.049). In the fundal region of JZ,
the expression of OTR in ovarian endometriosis was significantly lower than that in deep infiltrating endometriosis
(p = 0.046). The expression level of OTR in the funds region is positively associated with the severity of dysmenorrhea in
endometriosis group (r = 0.870, p < 0.05). Comparing to normal uteri, the expression of OTR in the secretory phase was
significantly higher in the endometriosis uteri (p < 0.05). In the fundus of endometriosis uteri, OTR expression was
significantly higher in both the proliferative and secretory phases (p = 0.045 and 0.028, respectively).
Conclusion: OTR expression in the JZ of women with endometriosis changes significantly, which may result in
abnormal uterine contractile activity, reducing the endometriosis-related fertility and dysmenorrhea.
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Background
Endometriosis is a chronic disease characterized by the
abnormal growth of the endometrial gland and stroma
are present in locations other than the lining of the
uterus [1, 2]. The JZ, also known as the inner myome-
trium, is the transitional interface between the endomet-
rium and the outer myometrium [3]. It is not only
functionally but also structurally different from the outer
myometrium. In the non-gravid uterus, myometrial con-
tractions exclusively distribute from this layer and their
amplitude, frequency, and orientation are correlated with
menstrual cycle phase [4–6]. These uterine contractions
play vital roles in several reproductive processes, including
of menstrual flow regulation, rapid sperm transport, suc-
cessful implantation and deep placentation [5, 7–9]. The
JZ seemingly gets involved in the process that determines
endometriosis, infertility or pelvic pain. There was a study
demonstrated the JZ contractions of isthmic in the prolif-
erative phase were responsible for rapid sperm transport
[9]. As for characterization of JZ, the three-dimensional
transvaginal sonography can prove to be an accurate diag-
nostic tool that can be performed easily and repeatedly in
patients with endometriosis in lower and advanced stages.
The maximum thickness and alteration of JZ in women
with endometriosis are significantly greater than those in
women without endometriosis [10]. Endometriosis is often
associated with JZ alteration even in the minimal and mild
stages. JZ alteration could be considered as a beneficial and
indirect sign to make a minimally invasive diagnosis of the
disease. Thus, an accurate and analytical evaluation of JZ
and its potential modification provides important informa-
tion for women with endometriosis [11].
It is agreed that oxytocin, which can significantly
increase the frequency of uterus peristaltic contractions,
is one of the most vital mediators for regulating the con-
traction of uterus, not only in pregnancy but also during
the non-pregnant states [5, 12, 13]. Oxytocin receptor is
widely expressed in epithelial cells and smooth muscle
cells of human uterus and peritoneal endometriotic
lesions and ovarian endometriotic cysts [14]. Real time
ultrasound has demonstrated peristaltic-like movements
which are oxytocin-dependent are confined to the endo-
metrium and JZ in non-pregnant uterus [5, 9]. Accord-
ing to the phases of menstrual cycle, many studies have
shown the change of the amplitude, frequency and direc-
tion of the contractions of the junctional zone in normal
uterus and uterus with endometriosis [5, 7, 8, 15]. Com-
pared to the control, women with endometriosis showed
an obvious uterine hyperperistalsis and dysperistalsis
[15]. We previously showed the higher serum oxytocin
level and higher frequency uterine contractions in endome-
triotic patients [16]. Abnormal uterine contractile activity
might underlie important disorders such as dysmenorrhea,
infertility, endometriosis, implantation failure, spontaneous
miscarriage or preterm birth [17]. Strong evidence proves
that uterus hyperperistalsis is significantly related to the
progression of endometriosis [18]. To date, our knowledge
is incomplete about the pathophysiologic mechanism
governing eccentric contractile activity in the junctional
zone in women of endometriosis. As far as we know OTR
expression in the isthmus and fundus of JZ of at different
menstrual phases in endometriosistic women has not been
studied. Therefore, to understand the pathophysiological
mechanisms governing abnormal uterine contractions sur-
veyed in endometriosis, we inspected the OTR expression
in isthmic and mid-fundal parts of the uterus at different




The study was approved by the Ethics Committee of the
First Affiliated Hospital of Medical University of Anhui
(reference number: PJ20160409). There were two groups
of patients with and without endometriosis. The mean
age of patients in the endometriosis and control groups
was 42.3 ± 3.9 and 41.5 ± 4.1 years old, respectively. The
inclusion criteria for women with endometriosis were
who had regular menstrual cycles (23–35 days), histolog-
ically confirmed endometriosis, experienced dysmenor-
rhea or not, received no hormone therapy or used an
intrauterine device ≥ six months before hysterectomy.
The exclusion criteria for study group were menopausal,
adenomyosis, pelvic inflammatory disease and pregnancy
3 months before hysterectomy. Endometriosis and ade-
nomyosis came to be seen as distinct entities. MRI is the
method of choice for imaging and evaluation of JZ as an
important diagnostic marker in the diagnosis of adeno-
myosis [19]. Because adenomyosis can be confidently
diagnosed using MRI when the altered junctional zone
thickness is greater than 12 mm and the expression
pattern of oxytocin receptor in the junctional zone in
women with adenomyosis had been studied by Zhang,
women with evidence of adenomyosis were excluded
from the scope of this study [20, 21]. The strict inclusion
and exclusion criteria can insure the validity of causal
relationship of the findings with the endometriosis
against the probably confounder factors exist in our
study. The control group included women with regular
menstrual cycles who underwent hysterectomy due to
cervical intraepithelial neoplasia III (CIN III) or stage I
cervical cancer, but with no history of primary dysmen-
orrhea, no evidence of endometriosis and adenomyosis
through gynecological and sonographic examination
before surgery, no hormone therapy or use of an intrauter-
ine device ≥ six months before surgery. There were no
evidences of endometriosis and adenomyoisis through
surgical examination and histology after surgery. According
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with the principle of ethics, all samples containing endo-
metrium and junctional zone must from the excised
uterus. There was no evidence that OTR expression in
smooth muscle cells of CIN III or stage I cervical cancer
changed comparing with normal uterus. In many studies
about OTR expression in smooth muscle cells, CIN III or
stage I cervical cancer patients were listed as control
groups [13, 20]. Therefore, we incline to the view that
OTR expression in JZ of CIN III or stage I cervical cancer
patients have no changed compare with normal uterus.
Based on the endometrial histology, there were 21 women
with endometriosis, 15 women in the proliferative phase
and 6 women in the secretory phase, as well as 48 women
without endometriosis, with 26 women in the proliferative
phase and 22 women in the secretory phase. In the control
group, 9 patients suffered from secondary dysmenorrhea
due to uterine leiomyoma. Dysmenorrhea is one of the
most prevalent symptoms of uterine leiomyoma. High ex-
pression of myostatin and matrix- metalloproteinases-14 in
uterine leiomyoma correlate with the presence of svere
dysmenorrhea [22]. In many studies about OTR expression
in smooth muscle cells, uterine leiomyoma patients were
listed as control groups [13, 23]. Staging of endometriosis
was performed according to the revised classification of
the American Society of Reproductive Medicine (revised
ASRM: I = 4; II = 2; III = 8, IV = 7). Seventeen ovarian
endometriosis (OEM) and four deep infiltrating endometri-
osis (DIE) patients were in the study group. The severity of
the recent dysmenorrhea in the endometriosis group was
evaluated by a 10-cm Visual Analog Scale (VAS) before the
surgery. The characteristics of the recruited patients of the
case and control groups are listed in Table 1.
Histological specimens
The uterine junctional zone was defined as the inner
third of the myometrium [24]. All samples containing
endometrium and junctional zone were collected from
the mid-fundal and isthmic areas of the uterine anterior
wall. The uterus was opened along the sagittal plane
after surgery. Multiple 1 × 1 × 1 cm3 samples were col-
lected and fixed in buffered formaldehyde and processed
routinely for paraffin embedding. Serial 4 μm sections
were prepared from each paraffin-embedded tissue block
and handled for immunohistochemical staining. All
uterine samples were examined by optical microscope to
confirm presence of endometriosis, absence of adeno-
myosis and respective phases of the menstrual cycle.
Under low light microscopy magnification, the uterine
junctional zone was located just 3 mm below the endo-
metrium [20].
After routine de-paraffinization and rehydration pro-
cedures, the slides were heated in a microwave oven
(700 W) in citrate buffer saline (9.0) for twelve min and
cooled at room temperature for antigen retrieval. Every
sections were incubated with a drop of 3% H2O2 deion-
ized water (PV-6000, Wuxi, China) for 20 min at 37 °C
temperature. After 2 washes with phosphate-buffered sa-
line (PBS), the slides were hatched with polyclonal rabbit
anti-OTR (1:100 dilution, bs-1314R, Bioss, Beijing,
China) overnight at 4 °C refrigerator. After 3 washes
with phosphate-buffered saline (PBS), the sections were
incubated with biotinylated anti-rabbit immunoglobulin
G (1:400) for 30 min at room temperature. The bound
antibody complexes were stained for 3 mins with diami-
nobenzidine. The slides were then washed, counter-
stained with hematoxylin, dried and mounted. Negative
control sections were processed by omitting the primary
antibody. Myometrium of pregnant uterus were used as
positive controls. Immunoreactivity staining was charac-
terized quantitatively by digital image analysis on the
Image Pro-Plus 6.0 (Nikon, Japan). Images were obtained
with a microscope fitted with a digital camera. A series
of 4 random images on several sections were taken for
each immunostained parameter to obtain a mean value.
Staining was defined by color intensity, and a color mask
was made. The mask was then applied equally to all
images, and measurements were obtained. Immunohis-
tochemical parameters were assessed in the area de-
tected by total optical density and mean optical density,
which is equivalent to the intensity of staining in the
positive cells.
Statistical analysis
The results were presented as mean ± standard error of
the mean. Statistical Program for Social Sciences (SPSS)
for windows version 16.0 (IBM Corp, Armonk, NY,
USA) was used to perform statistical analysis. Statistical







Age (in year; mean ± SD) 42.3 ± 3.9 41.5 ± 4.1 .419
Menstrual phase
Proliferative 15 26 .179
Secretory 6 22
Indications for hysterectomy NA
Cervical cancer 2a 36
Ovarian endometriosis 15 0
Deep infiltrating endometriosis 4 0
CIN III 0 12
History of dysmenorrhea
No 0 (0%) 39 (81.3%) .000
Yes 21 (100%) 9 (18.7%)
NA not applicable
aovarian endometriosis
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comparison of data was carried out by Student’s t-test
for non-paired samples. The normality tests showed
that all data were in normal distribution. To evaluate
possible effect of OTR expression levels on VAS score,
a linear regression model was used. P-value less than <0.05
(p < 0.05) were considered statistically significant.
Results
The staining of OTR expression in the control uterus is
showed in Fig. 1 and the quantitation of OTR expression
in Fig. 2. OTR expression in the isthmic region of JZ
was significantly higher than in the fundal region in the
proliferative phase (p = 0.048) but significantly lower in
the secretory phase (p = 0.012). In both isthmic and
fundal regions of JZ, OTR expression in the proliferative
phase was significantly higher than that in the secretory
phase (p = 0.000 and 0.049, respectively). OTR expres-
sion in patients with dysmenorrhea of control group was
no significant difference from that of patients without in
both isthmic and fundal regions of JZ (p = 0.154 and
0.175, respectively).
The staining and quantitation of OTR expression of JZ
in the endometriosis uteri are showed in Figs. 3 and 4,
respectively. OTR expression in the isthmic region
was slightly, but not significantly, lower than in the
fundal region in both proliferative and secretory
phases (p = 0.597 and 0.736, respectivley). In both
isthmic and fundal regions, the expression of OTR
was not significantly different between the prolifera-
tive phase and secretory phase (p = 0.084 and 0.222,
respectively). In the fundal region of JZ, the OTR ex-
pression was no significant difference between rASRM
I and rASRM II stages of endometriosis (p = 0.919).
Similarly, there was no significantly different of OTR
expression in fundal part of JZ between rASRM III
and IV stages of endometriosis (p = 0.445). However,
OTR expression in fundal regions of revised ASRM I
and II endometriosis were lower than that of revised
ASRM III and IV (p = 0.049). The OTR expression in
the isthmic region of JZ in ovarian endometriosis was
no significantly different from that of deep infiltrating
endometriosis (p = 0.357). In the fundal region of JZ,
the expression of OTR in ovarian endometriosis was
significantly lower than that in deep infiltrating endo-
metriosis (p = 0.046).
In the isthmic region, the expression of OTR in the
endometriosis uteri showed no significant difference
with that in control uterus in the proliferative phase
(p = 0.139). However, the expression of OTR in the
secretory phase was significantly higher in the endo-
metriosis uteri (p = 0.007). In the fundal region of
endometriosis uteri, the expression of OTR was signifi-
cantly higher than that in the control uteri in not only the
proliferative but also the secretory phases (p = 0.045 and
0.028, respectively) Fig. 5.
We have also found that OTR expression level in the
funds region is positively correlated with the severity of
dysmenorrhea in women with endometriosis (r = 0.870,
p < 0.05, Fig. 6).
Discussion
The temporal and spatial OTR distribution in the
normal uterus would both change during the menstrual
cycle, which are consistent with Zhang et al. [20]. The
elevation of OTR expression in the isthmic is to induce
an increase uterine contractility of the isthmic part in
the proliferative phase. As reported, the velocity and
frequency of uterine contractions were maximized at the
Fig. 1 Representative staining of mild cytoplasmic OTR expression in myometrial cells of JZ in the control group (arrow). a Isthmus region in the
proliferative phase. b Fundus in the proliferative phase. c Isthmus region in the secretory phase. d Fundus region in the secretory phase
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pre-ovulatory phase of the follicular cycle. They also sur-
veyed that constructions of cervix to fundal pattern were
dominant at this phase of the follicular cycle [25–28]. This
type of uterine contractions, which aspirate sperm into the
cervical part and the uterine cavity, controls the rapid sus-
tained sperm transport and provides forces into the isthmic
part of the tubes where they are available for fertilization
[29]. In contrast, OTRs were significantly lower in the isth-
mic part in the secretory phase. The uterine contraction
wave at the luteal phase consists of cervico-fundal contrac-
tions and isthmus contractions [30]. Both types of uterine
peristaltic activities become less frequent by the end of the
menstrual cycle. For each contraction started in the isthmi-
cal region, only one fourth reaches the fundal region in the
late luteal phase. This means the contractions render the
fundal region with relative peristaltic quiescence during the






















































































Fig. 2 Comparisons of oxytocin expression level in the isthmus and fundus of control uterus in different menstrual cycles. OTR expression in the
isthmic region was significantly higher than in the fundal region in the proliferative phase (p < 0.05) but significantly lower in the secretory phase
(p < 0.05). In both isthmic and fundal regions, OTR expression in the proliferative phase was significantly higher than that in the secretory phase
(p < 0.05). OTR expression in patients with dysmenorrhea of control group was no significant difference from that of patients without in both
isthmic and fundal regions of JZ (p > 0.05). Data are expressed as mean ± standard error of the mean
Fig. 3 Representative staining of strong cytoplasmic OTR expression in myometrial cells of JZ in the endometriosis group (arrow). a Isthmus region in
the proliferative phase. b Fundus in the proliferative phase. c Isthmus region in the secretory phase. d Fundus region in the secretory phase

































































Fig. 4 Comparisons of oxytocin expression level in the isthmus and fundus of endometriosis uterus in different menstrual cycles. OTR expression
was not significantly between the isthmic and fundal regions in both proliferative and secretory phases. (p > 0.05). In both isthmic and fundal
regions, the expression of OTR in the proliferative phase was not significantly different from secretory phase (p > 0.05). In the fundal region of JZ,
the expression of OTR in ovarian endometriosis was significantly lower than that in deep infiltrating endometriosis (p < 0.05). Data are expressed
as mean ± standard error of the mean
Fig. 5 Comparisons of oxytocin receptor expression level between control and endometriosis uteri in the proliferative and secretory phases. In
the isthmic region, the expression of OTR in the secretory phase was significantly higher in the endometriosis uteri (p < 0.05). In the fundal region
of endometriosis uteri, the expression of OTR was significantly higher than that in the control uteri in both the proliferative and the secretory
phases (p < 0.05). Data are expresses as mean ± standard error of the mean
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In uterine myometrial cells, OTR expressions are
induced by estradiol stimulation and down-regulated by
progesterone application [31–34]. OTR concentrations
are higher during the proliferative phase than the
secretory phase [35–37]. Consistent with these findings,
our study revealed OTR expression of control uteri in
the proliferative phase showed higher significance differ-
ence compared with that in the secretory phase in both
isthmic region and fundal region, presumably reacting
the positive and negative effects of estrogen and proges-
terone activity on oxytocin receptor synthesis and deg-
radation respectively [31, 38]. 17β-estradiol (E2), which
can be locally secreted by endometriotic cells, plays a
vital role in development and progression of endometri-
osis [39]. The OTR distribution in endometriosis uteri is
altered by excessive estrogen. OTR expression was not
significantly different between the isthmic and fundal re-
gions at either proliferative or secretory phases. This
may be one reason why endometriosis had an obvious
uterine hyperperistalsis and dysperistalsis, which preju-
dice the forces for rapid and sustained sperm transport
into tube ipsilateral to the dominant follicle [12, 18, 29].
Women with endometriosis display a marked increase
in uterine contraction compared with women free of dis-
ease [15, 16, 40]. The frequency of peristaltic activity is
doubled at the early and mid-menstrual phase of the
cycle compared with normal women [15]. The frequency
of peristaltic activity is similar to that obtained in normal
women with intravenous injection of oxytocin [41].
During menstruation, the frequency, amplitude and inci-
dence of retrograde uterine contractions in women with
endometriosis were much higher than in women without
endometriosis [42]. Our previously study revealed
women with endometriosis displayed higher frequency
uterine contract activity. We also found that dysperistal-
sis uterine contractions referred to some of the contrac-
tions originating in the middle portion of the uterus and
spreading simultaneously to the fundus and the cervix.
Other contractions that started simultaneously at differ-
ent sites vanished before they had reached the fundal
part of the uterus [16]. Hysterosalpingoscintigraphy re-
vealed that in the early and mid-follicular phases,
women with endometriosis displayed hyperperistalsis
that resulted in a dramatic increase transportation of
inert particles from the vagina, through the uterus into
the oviduct and also into the peritoneal cavity [15].
Hyperperistalsis results in desquamation of viable frag-
ments of basal endometrium and enhanced trans-tubal
dissemination of these fragments. These fragments
might implant some certain sites of the peritoneal cavity
[18]. These viable endometrial cells ultimately develop
into endometriotic implants. Therefore, the alterations
of uterine peristaltic activity play a causal role in the
pathogenesis of endometriosis. As reported, volumes of
endometriotic implants in rats were significantly reduced
by treatment with an OTR antagonist. It indicated that
an OTR antagonist may be an important effective drug
to decrease dissemination and thereby to combat
Fig. 6 The severity of dysmenorrhea measured by the VAS as function of the OTR expression levels in women with endometriosis. OTR expression
level in the funds region is positively correlated with the severity of dysmenorrhea (r = 0.872, p < 0.05)
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endometriosis [43]. Blocking OTRs for endometriosis
treatment may indirectly inhibit the synthesis aromatase
enzyme and the controlled hyper-estrogenic state of the
implants.
Dysmenorrhea is related to an elevated basal intrauter-
ine pressure tone and alters the frequency, amplitude
and duration of uterine contraction [44]. Since uterine
contractions of the JZ in non-pregnant uterus are oxyto-
cin dependent, OTR may be involved in dysmenorrhea.
Combining with oxytocin, excessive and irregular oxyto-
cin receptor causes higher intrauterine pressure which is
related to dysmenorrhea. Our previous study displayed
that women with endometriosis showed higher serum
oxytocin level [16]. As reported, the uterus contractile
amplitude and OTR expression level in myometrial
smooth muscle cells were both significantly higher in ade-
nomyosis cases than in controls, and related positively to
adenomyosis-associated dysmenorrhea which is connected
with increased uterine contractility. Andrographolide
which inhibits OTR expression can normalize uterine
contractility and pain alleviation [13]. DIE is recognized as
the most severe clinical form of endometriosis and it is as-
sociated with severe pain symptom [45]. This maybe can
explain the OTR expression in fundal region of JZ in DIE
endometriosis patients was higher than that of OEM
patients. OTR expression change in the myometrial
architecture of uteri having adenomyosis support the
hypothesis that dysperistalsis plays an essential role in
the development of endometriosis and dysmenorrhea
[23]. Besides the cause of uterine hyperactivity, OTR
expression up-regulates COX-2 and PGF2αwhich is
known as a pain mediator [46]. PGF2αcan further in-
crease the level of Oxytocin and PGE2 [47–50]. PGF2α
Combed with PGE2, can cause COX-2 overproduction
[51], which in turn increases PGE2 synthetize, and thereby
causes dysmenorrhea in endometriosis. Similarly, we pro-
vide that endometriosis-associated dysmenorrhea corre-
lates positively with OTR expression level in the JZ (Fig. 6).
The main limitation of our study was small size. We
believe that this result needs future larger, adequately
powered investigation.
In normal uterus, uterine contraction frequency and
amplitude increased from mid-cycle to maximum values
in the late luteal phase. Retrograde uterine activity is
most frequent at mid-cycle, which ensures the sperm
transport to the distal end of the tubes [28]. In the
isthmic region of endometriosis uteri, the expression of
OTR showed no significant difference in both the prolif-
erative and secretory phase. At mid-cycle, peristaltic
activities in women with endometriosis are replaced by
more convulsive uterine activities [15]. This change has
a profound effect on the directed sperm transport.
Passive sperm transport in the pre-ovulatory is impeded
dramatically by uterine dysperistlasis, which induce a
reduced aspiration of sperm into the uterine cavity and a
seriously impaired directed transport into the tube
ipsilateral to the dominant follicle [15]. We assume that
the inefficient sperm transport induced by decreased
peristalsis may be involved in infertility associated with
endometriosis.
This study reveals the expression of OTR in the
fundal region in endometriosis uteri was significantly
higher compared with normal uteri in both the prolif-
erative and secretory phases. We also displayed that
uterine contract activities were positively correlated
with serum of oxytocin levels and patients with endo-
metriosis had higher frequency uterine contractions
than in the tubal factor group in our former experi-
ments [16, 52]. Thus, we speculated the OT/OTR
system in endometriosis may result in hyperperistalsis
and poor endometrial receptivity. Uterine peristalsis
provides the forces for embryo migration, but ad-
versely affects the likelihood of pregnancy if the peri-
staltic frequency is too high [53]. It is estimated that
uterine contraction at the time of embryo transfer,
especially fund-cervical contractile activity, could
expel embryos from the uterus [54]. Patients with
uterine peristalsis of >3.0 waves/min before embryo
transfer had a lower chance of pregnancy compared
with those with lower frequencies [55]. In our previ-
ous study, uterine contractions were harmful to
embryo implantation and women with more uterine
contract activities are more likely to be repeated
implantation failures [51]. Atosiban, can compete with
OT of OTR in uterine smooth muscle cells, decidual
cells, and fetal membranes and inhibits OT-induced
PGF2a and uterine activities [56]. Some perspective
cohort studies show that atosiban may benefit pa-
tients who suffer from repeated or once implantation
failure undergoing IVF/embryo transfer with cryopre-
served embryos [57–59]. Our former study has indi-
cated application of atosiban improved the clinical
pregnancy and implantation rates in patients with
emdometriosis-associated infertility [16]. Atosiban can
relax uterine arteries and improve uterine endometrial
receptivity in pregnant rats [60, 61]. One potential
mechanism about the beneficial effects of atosiban on
implantation and pregnancy is its inhibitory effects on
uterine contractions [57].
Conclusions
The OTR expression in the uterine junctional zone of
women with endometriosis appears to have changed
significantly and irregularly. The abnormal expression
pattern of oxytocin receptor in the JZ in women with
endometriosis may result in abnormal uterine contractile
activity, reduced fertility and dysmenorrhea associated
with endometriosis.
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